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Summary 
Nerve Growth Factor (NGF), the prototype of the neurotrophin family, is essential for 
maintenance and growth of different neuronal populations. The X-ray crystal structure of 
NGF is known since early ‘90s and shows a β-sandwich fold with extensive loops, involved 
in the interaction with its binding partners. Understanding the dynamical properties of 
these loops is thus important for molecular recognition. We present here a combined 
solution NMR/molecular dynamics study which addresses the question of whether and 
how much the long loops of NGF are flexible and describes the N-terminus intrinsic 
conformational tendency of the unbound NGF molecule. NMR titration experiments 
allowed identification of a previously undetected epitope of the anti-NGF antagonist 
antibody αD11 which will be of crucial importance for future drug lead discovery. The 
present study thus recapitulates all the available structural information and unveils the 
conformational versatility of the relatively rigid NGF loops upon functional ligand binding. 
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Introduction 
Nerve Growth Factor (NGF), the prototype of the neurotrophin family, is essential for 
maintenance and growth of different neuronal populations in the nervous systems (Levi-
Montalcini, 1987). Alterations in its homeostatic regulation are involved in severe 
pathologies (Mysona et al., 2015; Tiveron et al., 2013). NGF is translated as a precursor, 
proNGF, with distinct biological functions (Hempstead, 2014). An early event in NGF signal 
transduction is the interaction with p75NTR and/or TrkA receptors (Lewin and Carter, 2014). 
Because of its role in the pathway of pain (Capsoni, 2014; Kelleher et al., 2016), there is a 
substantial interest in developing NGF mimetics endowed with antagonistic properties. 
However, this strongly relies on a detailed knowledge of its structure and of the 
interactions with its receptors.  
The X-ray crystal structures of NGF have been known since early 90s (Holland et al., 
1994; McDonald et al., 1991). NGF is an obligate non-covalent head-to-head homodimer 
with three loops (I, II and V) at one end of the molecule, whereas the opposite end 
contains a loop structure (III) and the conserved cystin-knotted arrangement of the three 
intra-chain disulphide bonds. A distinctive feature of NGF are its long unstructured loops (I, 
II, III and V), important for its interactions with the binding partners.  
Also available are the structures of NGF bound to its receptors (Feng et al., 2010; He and 
Garcia, 2004; Wehrman et al., 2007; Wiesmann et al., 1999), neutralizing antibodies 
(Covaceuszach et al., 2008; La Porte et al., 2014) and small ligands, such as 
lysophospholipids (Sun and Jiang, 2015; Tong et al., 2012) and DNA-aptamers (Jarvis et 
al., 2015). These studies have led to an emerging picture of the binding determinants on 
NGF to its key receptors.  
Despite the wealth of structural information obtained from the extensive crystallographic 
investigations, some significant questions have remained elusive: i) is the NGF N-terminus 
unstructured in the absence of ligands or does it have already some intrinsic 
conformational tendency? ii) how flexible/rigid are the loops and how their dynamics may 
reflect on the overall structural plasticity of mature NGF? iii) how much do the loops 
contribute to antibody recognition? 
Structural information is thus extremely important, in view of structure-based design of 
effective non-peptidic antagonists of NGF activity on TrkA receptor. Accumulating 
evidence shows that the NGF N-terminus plays a role in a number of processes. An N-
terminus truncated form of NGF has a significant drop in affinity for TrkA and in the ability 
of eliciting TrkA phosphorylation (Hughes et al., 2001; Kahle et al., 1992) which could not 
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be ascribed to differences in folding or stability (Woo et al., 1995). In one of the two crystal 
structures of NGF purified from mouse salivary glands (mNGF), the N-terminus is absent  
(Holland et al., 1994) whereas in the other neither N- nor C- termini were defined 
(McDonald et al., 1991). The N-terminus in recombinant human NGF (hNGF) or mouse 
proNGF in complex with p75NTR  are not defined (Feng et al., 2010; He and Garcia, 2004). 
Only in the hNGF/TrkA complex (Wehrman et al., 2007; Wiesmann et al., 1999) and in one 
of the two protomers of a complex with a DNA aptamer (Jarvis et al., 2015), the N-
terminus is defined and folded in an α-helix. The generally accepted view is thus that the 
N-terminus is disordered in the NGF unbound state (Berrera et al., 2006; Settanni et al., 
2003). Similar conclusions have been recently reached as result of CD and NMR solution 
studies and molecular dynamics simulations on two linear hNGF N-terminus peptides  
(Stanzione et al., 2010; Travaglia et al., 2015).  
It is difficult to infer from the X-ray data whether the variations reflect authentic flexibility or 
rather a structural plasticity. The two terms are similar but not equivalent: in the context of 
a protein, we would consider plasticity the capacity of a region to change the conformation 
permanently under, for instance, an interaction; flexibility is the property of a region (e.g. a 
loop) not to have a fixed conformation. In other words, one is a static concept, the second 
dynamic. The difference is particularly important for the design of antibodies directed 
against specific regions of NGF. Among the existing anti-NGF antibodies, the well 
characterized therapeutic MAb αD11 (Cattaneo et al., 1988; Covaceuszach et al., 2012) is 
particularly interesting as a structural probe, because it recognizes preferentially the 
mature form of the NGF versus proNGF (Paoletti et al., 2009). This property has been 
used to study the mechanistic consequences of inducing experimentally an imbalance in 
NGF/proNGF (Capsoni and Cattaneo, 2006; Capsoni et al., 2011). The MAb αD11 epitope 
has been characterized by ELISA, and the structure of the complex of rat αD11FAb and 
hNGF was obtained by in silico computational docking and validated by SAXS 
experiments (Covaceuszach et al., 2008).   
We present here a study in solution which addresses the open questions. Using a 
combination of nuclear magnetic resonance (NMR) and molecular dynamics (MD), we 
describe the N-terminus intrinsic conformational preferences of unbound NGF in solution. 
We show that also in the absence of partners the NGF N-terminus has a strong tendency 
to fold into a helix, challenging the current view that this region is unstructured. Our study 
also sets a definitive word on the structural plasticity of NGF loops II and V and provides a 
structural explanation for the large differential affinity of the αD11 anti-NGF therapeutic 
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antibody for NGF versus proNGF. We demonstrate by in solution NMR epitope mapping 
with the MAb αD11 the presence of a previously undetected epitope. The present study 
thus fills a gap in our structural understanding of NGF inter- and intra-molecular 
interactions and provides a strong basis for the design of more selective NGF antagonists. 
 
Results 
Solution NMR structure of mouse NGF 
Assigning the NMR spectrum to the specific protons of a protein is the prerequisite to map 
interactions and any conformational change. At 30°C, the 2D 1H -15N HSQC of mNGF is 
optimal and reveals a wide dispersion of signals characteristic of proteins with a 
predominantly β-sheet content which is consistent with the X-ray structure. The indole 
correlations of the three Trp residues are clearly observable in the distinctive and typically 
isolated region of the spectrum around 10.5 ppm (1H) and 135 ppm (15N). All Gln and Asn 
side chains are detected. We achieved virtually full assignment of the spectrum. 
Conversion of the NOE information into a structural model was not trivial because the 
potential symmetry (two-fold) of the homodimer makes it hard to distinguish between intra 
and inter-molecular NOEs. The problem, which has been debated for years (Nilges and 
O’Donoghue, 1998; Saudek et al., 1991), was circumvented thanks to the software support 
of ARIA (Rieping et al., 2007) which allows discrimination of intra- from inter-molecular 
NOEs and careful iterative analysis of the violations (Table 1). The process led eventually 
to a well compact bundle (Figure 1A) with a root mean square deviation (r.m.s.d.) of 1.3 Å 
for the bundle from the structure with minimal global energy as calculated on 236 residues 
(Figure 1B). It closely resembles the available X-ray structures, especially in the Cys-knot, 
while exhibiting larger variability in the loop regions (Figure 1C). The r.m.s.d. values 
between the structure with minimal global energy and the crystal structures of unbound 
mNGF (PDB ID 1BTG, protomers B,C) or NGF bound to lipids (PDB ID 4EAX or 4XPJ) for 
the backbone atoms of the core residues (15-22, 51-58, 78-89, 100-111) which exclude 
the loops are 2.32 Å, 2.14 Å and 2.12 Å respectively. The structure in solution allows us to 
address a number of crucial aspects as detailed in the next sections.  
 
The structure of the NGF N-terminus 
From our data, we can obtain direct information on the structure of the N-terminus 
(residues S1-M9) from the NOE patterns. In solution, the N-terminus whose resonances 
can be observed distinctly, does not adopt a regular secondary structure. However, a 
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number of medium-range NOEs were observed between the backbone and side-chains of 
these residues, suggesting the existence of a short nascent helical turn (residues 6-10). 
The average Oi…NHi+3 and Oi…NHi+4 distances between residues S2-G10 were measured 
for the 20 lower global energy models to check the presence of  distances compatible with 
hydrogen bonds. Overall, the V6-G10 segment has a clear propensity to form a short helix, 
the Oi…NHi+3 and Oi…NHi+4 distances being within 2.6 Å and 6.1 Å over the whole bundle. 
In almost 50% of the 20 lower global energy models, the V6-G10 segment adopts either a 
310 helix or a α-helix conformation (Figure 1A, inset). These distances are within 2.1 Å and 
6.2 Å in the lower global energy model exhibiting a helical conformation. These results 
provide a clear answer to whether and how much the N-terminus is folded and clarify its 
tendency to fold in a helical conformation. The secondary chemical shifts, that is the 
difference between the observed values and the random coil values for the same amino 
acid, confirm a helical tendency of this region (data not shown).  
 
The NGF loops are in a slow conformational exchange 
While assigning the NGF spectrum which was troublesome due to significant overlap, it 
became clear that some interesting dynamical processes were going on. At 30°C the vast 
majority of the peaks have homogeneous intensity but a limited set of resonances of 
weaker intensity are observed (Figure 2A). After virtually full spectral assignment, these 
weaker resonances were found to be duplicate assignments for a small set of specific 
resonances which cluster around loops I and II and on the stem region (region IV-loop V) 
that points towards loop II (residues 39-47) (Figures 2B,C). Notably, W99, present in this 
region, shows doubling of the indole proton. Loop II, the region where most of the 
resonance splitting is observed, is also involved in small ligands binding (PDB ID 4EAX 
and 4XPJ). Peak doubling was furthermore observed for the side chains of a few residues 
in the 13C HCCH-TOCSY and 13C NOESY-HSQC spectra (data not shown). To test for 
the presence of conformational exchange, 15N HSQC spectra were recorded at 10°C 
intervals between 10°C and 40°C (Figure 2A). At 10°C, the peak intensity is highly 
heterogeneous with only ca. 30% of the number expected for a homodimer of 118 amino 
acids. By progressively increasing the temperature to 40°C, all the expected signals return, 
with the vast majority showing homogeneous intensity. However, a subset of secondary 
species of lower intensity remained observable. The overall quality of the spectrum is 
consistent with that expected for a homodimer of 26 kDa, with a line width indicative of the 
molecular size of the system. For a homodimeric protein, resonance doubling can be 
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explained in at least two possible ways. It could indicate an intrinsic local asymmetry of the 
homodimer over the NMR timescale. This possibility can, however, be ruled out since the 
most affected region around loop II is not engaged in the homodimer interface. 
Alternatively, it could arise from the presence of multiple conformational species in 
equilibrium on the slow-exchange timescale. This second possibility seems more likely 
given the dramatic change in the number and in the relative peak intensities observed in 
the 15N HSQC as a function of temperature. 
The data thus suggest that the NGF loops adopt different conformations in the slow 
exchange regime in the NMR timeframe.  
 
Dynamical features of the NGF loops 
We measured the T1, T2 and heteronuclear NOE (hetNOE) parameters to obtain 
information on the dynamics in solution. The experimental correlation time (τC) is 14.8 ns 
which is consistent with the expected molecular weight of the dimer. The T1, T2 and NOE 
values correlate well with the secondary structure (Figure 3A) and highlight the more rigid 
β-sheet regions. The loops, especially II and V, and the C-terminus are relatively more 
flexible showing hetNOE values lower than the average (0.7). However, overall, the 
hetNOE profile is relatively flat with some minor exceptions which could well be explained 
by residue overlap.  
Intrigued by these results, we run a molecular dynamics simulation of mNGF (200 
ns) to further explore the tendency of the N-terminus to adopt a helical conformation and 
the conformational space of the loop regions. The ensemble of structures sampled in the 
MD trajectory is variable, but in line with the NMR analysis (Figure 3B). Not having 
imposed any symmetry constraints we see of course a different behavior in the two 
protomers. Over the simulation time scale, all residues in the tract His4-Phe7 spend a 
significant percentage of time in a 310 or α-helix conformation at least in one of the 
protomers (Figure 3C). Residues H4-G10, in both protomers, unwind and fold during the 
simulation but are able to form transient hydrogen bonds mostly between the carbonyl 
oxygen of H4 and the amide hydrogen of F7 and the carbonyl oxygen of P5 and the amide 
hydrogen of H8. The carbonyl oxygen of V6 is also engaged only in one protomer in 
hydrogen bonds with the amide hydrogen of either M9 or G10 residues. The main-chain–
side-chain interactions between residues H4/F7, V6/M9 and F7/G10 are overall more 
preserved than the side-chain–side-chain interactions between residues P5/H8 and V6/M9 
as well as the interaction between the residues V6/G10. The MD results are in line with the 
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observed NOE contacts supporting that in at least one of the protomers (Table S1), a 
short segment within the central region of the mNGF N-terminus adopts a α-helix (15%) or 
a 310-helix (35%) conformation for a small but significant fraction of time (Figure 3D). 
According to these conclusions, a previous MD study on an isolated linear peptide 
spanning the N-terminus sequence (Stanzione et al., 2010) has shown that most of the 
adopted conformations do not present a regular secondary structure but a helical structure 
can form for a limited fraction of conformers in the ensemble.  
We can thus conclude that the NGF N-terminus comprises a nascent helix which 
can be further stabilized upon binding with its partners.  
 
Analysis of the loop motions 
The Cα r.m.s.d. along the MD trajectory shows that, besides the N- and C-termini, the 
regions encompassing loops II and V are comparably more flexible and exhibit large-scale 
conformational flexibility (Figure 3B). The loop variations are however relatively small as 
compared to the flexibility of the N- and C-termini. This indicates that the loops are plastic 
but not flexible in agreement with the differences observed in these regions in the 
crystallographic structures of apo mNGF (PDB ID 1BET, 1BTG) and in complex with 
lysophosphatidylserine (PDB ID 4EAX) and lysophosphatidylinositol (PDB ID 4XPJ). This 
information is of crucial importance for the development of small organic compounds 
(Brahimi et al., 2014) and peptidomimetics based on the combination of different NGF 
loops fragments (Colangelo et al., 2008). We thus analyzed the relative intra- and inter-
protomer distances between loops I, II, III and V (Figure S1). The shortest and the longest 
inter-protomer Cα distances between the Asn46 of Loop II are 11 Å (apo form PDB ID 
1BTG, protomers B,C) and 30 Å respectively (holo forms PDB ID 4XPJ, protomers A,B 
and PDB ID 4EAX, protomers A,B and C,D) indicating large scale motions. The 
corresponding distances, in the most representative MD structure (the most populated 
cluster center) and in the lowest global energy NMR structure are of 13 Å and 16 Å 
respectively. The longest and shortest inter-protomers distances between Lys95 of Loop V 
are of 42 Å (apo form PDB ID 1BTG, protomers B,C) and of 40 Å (holo form PDB ID  
4XPJ). The corresponding distances in the most representative MD structure (the most 
populated cluster center) and in the lowest global energy NMR structure are of 34 Å and 
37 Å respectively (Figure S1). 
For comparison, in the crystal structures of free and bound NGF, the conformation 
of loop II has high plasticity with an overall opening of the structure upon the 
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accommodation of the small ligands (Figure 1C). It is tempting to speculate that the 
conformational equilibrium experienced by loop II and V, supported also by resonance 
doubling, is functionally relevant for the biological activity of the molecule, including 
interactions with the binding partners, i.e. the receptors TrkA and p75NTR. These features 
highlight the differences between NGF and other homodimeric β-sandwich structures. 
We can thus conclude that NGF has long plastic but relatively rigid loops. This 
information is of crucial importance for drug design (Bannwarth and Kostine, 2014).  
 
Using the spectral assignment for antibody recognition studies 
Finally, we used the information gained in solution to study the interaction of NGF with 
αD11, one of the well characterized antibodies. We titrated 15N-labelled NGF with αD11 
using the MAb protein. We used sub-stoichiometric amounts of αD11 to avoid that, given 
the high affinity expected, the molecular weight of the complex could prevent the 
observation of the spectrum (Figure 4A). The most appreciable perturbations in the NGF 
spectrum occur in three distinct sets of resonances which disappear (V14, G23, F101, 
C110, V111), decrease in intensity (T26, L39, N45, N46, Y52, E65, D93, W99, R100, 
K115) or shift significantly (G10, S13, V18, A40, F49, T56, Y79, T81, T92, E94, K95, Q96, 
I102, V109) indicating slow, slow-intermediate and fast-exchange regimes, respectively. 
When mapping these regions onto the NGF structure, a set of the affected residues (V18, 
G23, T26, L39, A40, F49, Y52, D93, Q96, W99, R100, F101) overlap with those previously 
identified in the SAXS hNGF-αD11 FAb complex model (Covaceuszach et al., 2008) I. 
Additionally, residues G10-V14, V64-I71, T81 and V109-V111, which cluster close 
together in space, suggest a previously unidentified epitope (Figure 4B). Interestingly, this 
region is not included in the FAb-NGF contacts also in the crystal structures of the 
complexes of hNGF with the anti-NGF antibodies Tanezumab (PDB ID 4EDW) and its 
murine precursor MAb 911 (PDB ID 4EDX), whose epitopes are otherwise comparable to 
those of αD11 FAb. Thus, the solution NMR epitope mapping of the MAb αD11 unveiled a 
previously undetected epitope, further supporting why αD11 antibody binding differs 
significantly between mature NGF and proNGF: in the latter the pro-peptide could hinder 
the accessibility of the NGF surface to the antibody. 
 
Discussion 
NGF is an important molecule involved in the maintenance of numerous neuronal 
populations, and its alterations in metabolism are crucial for different neurological 
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disorders. The crystal structures of mNGF has been known for 25 years (Holland et al., 
1994; McDonald et al., 1991), but no solution structure has so far been available which 
could facilitate drug design and small molecule screening in solution. The present study 
fills this gap, by reporting the mNGF structure in solution and sheds light on local 
conformational and dynamical features supported by MD simulations.  
For the first time we have experimentally characterized the N-terminus of the 
protein, a dynamic and elusive segment of NGF which was previously only observed in the 
structure of recombinant hNGF in complex with TrkA receptor while it is cleaved or 
unobservable in other structures. This region is considered a structural determinant in 
NGF molecular recognition and selective binding of the TrkA rather than p75NTR receptor 
(He and Garcia, 2004; Wehrman et al., 2007; Wiesmann et al., 1999). Our data indicate 
that, in the context of the full length mNGF, a helical conformation is readily sampled in 
solution among the energetically favored states of this region as in a classical nascent 
helix. This result challenges the current view that the NGF N-terminus is unstructured and 
adopts a helical structure only upon binding to its partner TrkA (Wehrman et al., 2007). 
Our findings open up new strategies for the development of effective NGF N-terminal 
based bioactive peptide-based compounds as antagonists with high-affinity towards the 
TrkA receptor. 
From a careful analysis of the resonances in the 15N- and 13C-HSQC and the 
corresponding NOESY-HSQCs, it was also possible to identify the splitting of several 
resonances. The residues involved are all concentrated in the region of the molecule 
encompassing loops I and II and the facing region IV/loop V. The occurrence of these 
extra resonances likely results from a slow exchange between conformational species, 
thus pointing to an increased mobility of the loops II and V within the frame of an otherwise 
rigid molecule. Accordingly, these regions have relatively lower values of hetNOEs and a 
higher r.m.s.d. in our MD trajectory although overall the motions look only local. These 
observations agree with the structural information available for other members of the 
neurotrophin family (Banfield et al., 2001; Butte et al., 1998; Gong et al., 2008; Robinson 
et al., 1999) and with the observation that the region encompassing loops II and V is the 
one in which a conformational rearrangement/breathing is triggered by binding of 
lysophospholipids (Sun and Jiang, 2015; Tong et al., 2012). We can rationalize these 
results considering that loops II and V can be considered like forceps that open/close and 
are in a cross-talk to adapt and sequester the ligand. Loops I are spatially close to loops V 
but do not move. They could thus be considered like a "guard rail" in protection of 
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excessive motions of loops V and consequent disruption of the binding site formed by 
loops II and V. Loops III protects the cystine-knot. It is spatially far from loops I, II and V, 
but in proximity of the N- and C-termini. It is not flexible in agreement with its likely role of 
protection even though it is peculiar that this loop has partially defined electronic density in 
the crystallographic structures of human NGF in complex with the TrkA and p75NTR 
receptors, as well as in complex with the DNA-aptamer and with antibodies and it is 
among the less conserved in length and composition within the neurotrophin family 
members (NGF, BDNF, NT-3, NT-4).  
Finally, the present NMR study exploits the interaction between NGF and the MAb 
αD11 antibody allowing a fine mapping of the epitope: we observed a patch encompassing 
residues G10-V14, V64-I71, T81 and V109-V111, as being involved in addition to loop I 
and II which had already been identified (Covaceuszach et al., 2008). These regions face 
each other in the structure. The observation is important for the interpretation of the 
binding properties of αD11 which recognizes both mature and proNGF albeit with very 
different affinities (pM versus nM). Since αD11 is an NGF neutralizing antagonistic 
antibody (Covaceuszach et al., 2008), knowledge of the exact epitopes is of interest for 
interpreting mouse models and for the design of more effective antibodies.  
In conclusion, our study reports the first NMR study of mNGF in solution, and, more 
in general, of a neurotrophin and provides new insights into the dynamical features of NGF 
N-terminus and loops, opening the way to further studies aimed at a deeper understanding 
of NGF binding to its partners. It also paves the way to the determination of the high 
resolution structure of the mNGF precursor, mproNGF, whose only available 3D structural 
information is limited to low resolution SAXS studies (Paoletti et al., 2009) and preliminary 
solution NMR studies (Paoletti et al., 2011). 
 
Experimental Procedures 
Expression, refolding and purification of mNGF 
Recombinant mNGF was expressed in minimal medium, both as 15N and a 15N-13C 
labelled proteins, and purified as previously described (Paoletti et al., 2011). See 
Supplementary Information for details.  
 
NMR spectroscopy experiments 
NMR experiments and structure calculations were carried out using standard protocols 
(details in Supplementary Information). Briefly, HNCA, HNCO, HNCACB were used for 
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backbone assignments. 15N NOESY-HSQC, 13C NOESY-HSQC, CBCACONH and HCCH-
TOCSY were used for side chain aliphatic assignments. (Hβ)Cβ(CγCδ)Hδ and 
(Hβ)Cβ(CγCδ)Hε were used in combination with 13C-HSQC, 13C- NOESY-HSQC and 
HCCH-TOCSY tuned for the aromatic resonances for the assignment  of the aromatic side 
chains. All spectra were processed using NMRPipe/NMR-Draw (Delaglio et al., 1995) and 
analyzed using CARA (Keller, 2004). Backbone and side chain assignment was deposited 
in the BMRB database (accession code 34037). 
Relaxation parameters were obtained by spectra recorded at 600 MHz and 30°C and 
extracted using peak picking, lineshape fitting, and exponential modelling as implemented 
in NMRPipe (Delaglio et al., 1995).  
 
Structure Determination 
Automated NOESY cross-peak assignments and structure determination were performed 
using the ARIA 2.3 software (Rieping et al., 2007). The input used to generate the final 
structures consisted of NGF intra-molecular NOE cross peaks from 15N- and 13C-NOESY-
HSQC spectra (at 30°C and 35°C), along with a set of φ and ψ backbone dihedral 
restraints derived by TALOS+ (Shen et al., 2009) and a set of manually assigned 
unambiguous inter-protomer restraints. After refinement of the 60 lowest global energy 
structures by molecular dynamics simulation with explicit water, 20 structures ranked on 
global energy were selected as representative of the structure and used for statistical 
analysis. Structure quality was evaluated with PROCHECK-NMR (Laskowski et al., 1996). 
The details are reported in the Supplementary Information. 
The coordinates of the NGF structure are deposited in the PDB under the code 5LSD. 
 
Molecular Dynamics Simulations and Analysis 
A molecular model of the full length mNGF encompassing residues (2-118) was built 
(Covaceuszach et al., 2015) from the crystal structures of mouse bis-des-octa β-NGF 
(PDB ID 1BTG, protomers B,C). Molecular dynamics simulation (MD) was performed using 
the GROMACS software package (version 5.1.2) (Hess et al., 2008) conjugated with the 
Amber99SB force field. Details are reported in the Supplementary Experimental 
procedures. The utilities gmx distance and gmx cluster, provided in the GROMACS 
package, were used: i) to calculate the distances between pairs of positions as a function 
of time; ii) to cluster, in the post processing phase, the resulting trajectories with a cutoff of 
0.15 nm, calculated on the backbone atoms (Daura et al., 1999).  
Pr vis
iona
13 
 
Acknowledgments 
We gratefully acknowledge the help of Dr Giuseppe Nicastro (Crick Institute) for recording 
a set of NMR data and for helpful discussion, the assistance of Dr Andrea Delise (SISSA) 
with the software managing and the helpful suggestions of Dr Benjamin Bardiaux (Inst. 
Pasteur, Paris) for the ARIA software usage. 
 
Funding 
The research described here was funded by the European Community’s Seventh 
Framework Program Paincage Grant Nr 603191, MRC (U117584256), and MIUR, project 
PRIN #2010N8PBAA_006. FP was recipient of a Royal Society – Accademia dei Lincei 
Fellowship. 
 
References 
Banfield, M.J., Naylor, R.L., Robertson, A.G., Allen, S.J., Dawbarn, D., and Brady, R.L. (2001). 
Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex 
with neurotrophin-4/5. Structure 9, 1191–1199. 
Bannwarth, B., and Kostine, M. (2014). Targeting nerve growth factor (NGF) for pain management: 
what does the future hold for NGF antagonists? Drugs 74, 619–626. 
Berrera, M., Cattaneo, A., and Carloni, P. (2006). Molecular simulation of the binding of nerve 
growth factor peptide mimics to the receptor tyrosine kinase A. Biophys. J. 91, 2063–2071. 
Brahimi, F., Ko, E., Malakhov, A., Burgess, K., and Saragovi, H.U. (2014). Combinatorial 
assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors. PloS One 9, 
e89617. 
Butte, M.J., Hwang, P.K., Mobley, W.C., and Fletterick, R.J. (1998). Crystal structure of 
neurotrophin-3 homodimer shows distinct regions are used to bind its receptors. Biochemistry 37, 
16846–16852. 
Capsoni, S. (2014). From genes to pain: nerve growth factor and hereditary sensory and autonomic 
neuropathy type V. Eur. J. Neurosci. 39, 392–400. 
Capsoni, S., and Cattaneo, A. (2006). On the molecular basis linking Nerve Growth Factor (NGF) 
to Alzheimer’s disease. Cell. Mol. Neurobiol. 26, 619–633. 
Capsoni, S., Tiveron, C., Vignone, D., Amato, G., and Cattaneo, A. (2010). Dissecting the 
involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF 
deficit-induced neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 107, 12299–12304. 
Capsoni, S., Brandi, R., Arisi, I., D’Onofrio, M., and Cattaneo, A. (2011). A dual mechanism 
linking NGF/proNGF imbalance and early inflammation to Alzheimer’s disease neurodegeneration 
in the AD11 anti-NGF mouse model. CNS Neurol. Disord. Drug Targets 10, 635–647. 
Cattaneo, A., Rapposelli, B., and Calissano, P. (1988). Three distinct types of monoclonal 
antibodies after long-term immunization of rats with mouse nerve growth factor. J. Neurochem. 50, 
1003–1010. 
Colangelo, A.M., Bianco, M.R., Vitagliano, L., Cavaliere, C., Cirillo, G., De Gioia, L., Diana, D., 
Colombo, D., Redaelli, C., Zaccaro, L., et al. (2008). A new nerve growth factor-mimetic peptide 
active on neuropathic pain in rats. J. Neurosci. 28, 2698–2709. 
Covaceuszach, S., Cassetta, A., Konarev, P.V., Gonfloni, S., Rudolph, R., Svergun, D.I., Lamba, 
Provis
ional
14 
D., and Cattaneo, A. (2008). Dissecting NGF interactions with TrkA and p75 receptors by structural 
and functional studies of an anti-NGF neutralizing antibody. J. Mol. Biol. 381, 881–896. 
Covaceuszach, S., Marinelli, S., Krastanova, I., Ugolini, G., Pavone, F., Lamba, D., and Cattaneo, 
A. (2012). Single cycle structure-based humanization of an anti-nerve growth factor therapeutic 
antibody. PloS One 7, e32212. 
Covaceuszach, S., Konarev, P.V., Cassetta, A., Paoletti, F., Svergun, D.I., Lamba, D., and Cattaneo, 
A. (2015). The conundrum of the high-affinity NGF binding site formation unveiled? Biophys. J. 
108, 687–697. 
Daura, X., Gademann, K., Jaun, B., Seebach, D., van Gunsteren, W.F., and Mark, A.E. (1999). 
Peptide Folding: When Simulation Meets Experiment. Angew. Chem. Int. Ed. 38, 236–240. 
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995). NMRPipe: a 
multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293. 
Feng, D., Kim, T., Ozkan, E., Light, M., Torkin, R., Teng, K.K., Hempstead, B.L., and Garcia, K.C. 
(2010). Molecular and structural insight into proNGF engagement of p75NTR and sortilin. J. Mol. 
Biol. 396, 967–984. 
Gong, Y., Cao, P., Yu, H., and Jiang, T. (2008). Crystal structure of the neurotrophin-3 and 
p75NTR symmetrical complex. Nature 454, 789–793. 
He, X.-L., and Garcia, K.C. (2004). Structure of nerve growth factor complexed with the shared 
neurotrophin receptor p75. Science 304, 870–875. 
Hempstead, B.L. (2014). Deciphering proneurotrophin actions. Handb. Exp. Pharmacol. 220, 17–
32. 
Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008). GROMACS 4:  Algorithms for 
Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Comput. 4, 
435–447. 
Holland, D.R., Cousens, L.S., Meng, W., and Matthews, B.W. (1994). Nerve growth factor in 
different crystal forms displays structural flexibility and reveals zinc binding sites. J. Mol. Biol. 
239, 385–400. 
Hughes, A.L., Messineo-Jones, D., Lad, S.P., and Neet, K.E. (2001). Distinction between 
differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant 
delta9/13, which is selective for the p75 neurotrophin receptor. J. Neurosci. Res. 63, 10–19. 
Jarvis, T.C., Davies, D.R., Hisaminato, A., Resnicow, D.I., Gupta, S., Waugh, S.M., Nagabukuro, 
A., Wadatsu, T., Hishigaki, H., Gawande, B., et al. (2015). Non-helical DNA Triplex Forms a 
Unique Aptamer Scaffold for High Affinity Recognition of Nerve Growth Factor. Structure 23, 
1293–1304. 
Kahle, P., Burton, L.E., Schmelzer, C.H., and Hertel, C. (1992). The amino terminus of nerve 
growth factor is involved in the interaction with the receptor tyrosine kinase p140trkA. J. Biol. 
Chem. 267, 22707–22710. 
Kelleher, J.H., Tewari, D., and McMahon, S.B. (2016). Neurotrophic factors and their inhibitors in 
chronic pain treatment. Neurobiol. Dis. doi: 10.1016/j.nbd.2016.03.025 
Keller, R. (2004). The Computer Aided Resonance Assignment Tutorial. 
La Porte, S.L., Eigenbrot, C., Ultsch, M., Ho, W.-H., Foletti, D., Forgie, A., Lindquist, K.C., 
Shelton, D.L., and Pons, J. (2014). Generation of a high-fidelity antibody against nerve growth 
factor using library scanning mutagenesis and validation with structures of the initial and optimized 
Fab-antigen complexes. mAbs 6, 1059–1068. 
Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R., and Thornton, J.M. (1996). 
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by 
NMR. J. Biomol. NMR 8, 477–486. 
Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154–1162. 
Lewin, G.R., and Carter, B.D. (2014). Neurotrophic Factors (Springer Berlin Heidelberg). 
McDonald, N.Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A., and Blundell, T.L. 
vi i a
l
15 
(1991). New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. 
Nature 354, 411–414. 
Mysona, B.A., Matragoon, S., Stephens, M., Mohamed, I.N., Farooq, A., Bartasis, M.L., Fouda, 
A.Y., Shanab, A.Y., Espinosa-Heidmann, D.G., and El-Remessy, A.B. (2015). Imbalance of the 
nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy. BioMed Res. 
Int. 571456. 
Nilges, M., and O’Donoghue, S.I. (1998). Ambiguous NOEs and automated NOE assignment. 
Prog. Nucl. Magn. Reson. Spectrosc. 32, 107–139. 
Paoletti, F., Covaceuszach, S., Konarev, P.V., Gonfloni, S., Malerba, F., Schwarz, E., Svergun, D.I., 
Cattaneo, A., and Lamba, D. (2009). Intrinsic structural disorder of mouse proNGF. Proteins 75, 
990–1009. 
Paoletti, F., Malerba, F., Kelly, G., Noinville, S., Lamba, D., Cattaneo, A., and Pastore, A. (2011). 
Conformational plasticity of proNGF. PloS One 6, e22615. 
Rieping, W., Habeck, M., Bardiaux, B., Bernard, A., Malliavin, T.E., and Nilges, M. (2007). 
ARIA2: automated NOE assignment and data integration in NMR structure calculation. 
Bioinformatics 23, 381–382. 
Robinson, R.C., Radziejewski, C., Spraggon, G., Greenwald, J., Kostura, M.R., Burtnick, L.D., 
Stuart, D.I., Choe, S., and Jones, E.Y. (1999). The structures of the neurotrophin 4 homodimer and 
the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding 
site. Protein Sci. 8, 2589–2597. 
Saudek, V., Pastore, A., Morelli, M.A., Frank, R., Gausepohl, H., and Gibson, T. (1991). The 
solution structure of a leucine-zipper motif peptide. Protein Eng. 4, 519–529. 
Settanni, G., Cattaneo, A., and Carloni, P. (2003). Molecular dynamics simulations of the NGF-
TrkA domain 5 complex and comparison with biological data. Biophys. J. 84, 2282–2292. 
Shen, Y., Delaglio, F., Cornilescu, G., and Bax, A. (2009). TALOS+: a hybrid method for 
predicting protein backbone torsion angles from NMR chemical shifts. J. Biomol. NMR 44, 213–
223. 
Stanzione, F., Esposito, L., Paladino, A., Pedone, C., Morelli, G., and Vitagliano, L. (2010). Role of 
the conformational versatility of the neurotrophin N-terminal regions in their recognition by Trk 
receptors. Biophys. J. 99, 2273–2278. 
Sun, H.L., and Jiang, T. (2015). The structure of nerve growth factor in complex with 
lysophosphatidylinositol. Acta Crystallogr. Sect. F 71, 906–912. 
Tiveron, C., Fasulo, L., Capsoni, S., Malerba, F., Marinelli, S., Paoletti, F., Piccinin, S., Scardigli, 
R., Amato, G., Brandi, R., et al. (2013). ProNGF\NGF imbalance triggers learning and memory 
deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. Cell 
Death Differ. 20, 1017–1030. 
Tong, Q., Wang, F., Zhou, H.-Z., Sun, H.-L., Song, H., Shu, Y.-Y., Gong, Y., Zhang, W.-T., Cai, 
T.-X., Yang, F.-Q., et al. (2012). Structural and functional insights into lipid-bound nerve growth 
factors. FASEB J. 26, 3811–3821. 
Travaglia, A., Pietropaolo, A., Di Martino, R., Nicoletti, V.G., La Mendola, D., Calissano, P., and 
Rizzarelli, E. (2015). A small linear peptide encompassing the NGF N-terminus partly mimics the 
biological activities of the entire neurotrophin in PC12 cells. ACS Chem. Neurosci. 6, 1379–1392. 
Wehrman, T., He, X., Raab, B., Dukipatti, A., Blau, H., and Garcia, K.C. (2007). Structural and 
mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 
53, 25–38. 
Wiesmann, C., Ultsch, M.H., Bass, S.H., and de Vos, A.M. (1999). Crystal structure of nerve 
growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–
188. 
Woo, S.B., Timm, D.E., and Neet, K.E. (1995). Alteration of NH2-terminal residues of nerve 
growth factor affects activity and Trk binding without affecting stability or conformation. J. Biol. 
P vis
io l
16 
Chem. 270, 6278–6285. 
Provis
ional
17 
Table 1 – NMR refinement statistics of NGF 
Completeness of resonance assignments  
Backbone (%) 97.3 
Side Chains (%) 72.9 
NMR distance and dihedral restraints  
Distance restraints  
  Total NOEs (used during calculations - per protomer) 2327 
    Unambiguous 2315 
    Ambiguous 12 
  Merged 4331 
  Intra-residuea 1346 
  Inter-residuea 969 
    Sequential (|i - j| = 1) 421 
    Nonsequential (|i - j| > 1) 548 
  Hydrogen bonds (per protomer) 46 
  No. of Noe restraints per residue 19.9 
Total dihedral angle restraintsb (per protomer)  
  Phi angles 55 
  Psi angles 56 
Inter-protomer restraints (per protomer) 33 
Structure statistics  
Violations  
Distance constraints (>0.3 Å) 5 
Deviations from idealized geometry (over 60 structures)  
  Bond lengths (Å) 0.0035 ± 0.00009 
  Bond Angles (°) 0.47 ± 0.016 
  Improper Angles (°) 1.46 ± 0.13 
Ensemble RMSD (over 60 structures in the refinement process)  
 All residues  
      Backbone (N,CA,C,O) (Å) 2.58 +/- 1.18 
      Heavy atoms (Å)        2.89 +/- 1.11 
Ordered residues  
      Backbone (N,CA,C,O) (Å) 1.44 +/- 0.64 
      Heavy atoms (Å) 1.77 +/- 0.57 
aStatistics among unambiguous restraints 
bTALOS-derived dihedral restraints 
cOrdered residues (for A and B protomers): 5-6, 14, 17-24, 27-38, 41-43, 47-48, 53-58, 63, 67, 70-71, 75-82, 
84-92, 97-112, 114. 
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Figure Legends 
Figure 1 - Solution structure of recombinant mNGF.  
A) Overlay of the 20 lower global energy models after ARIA refinement in water. Inset: 
subgroup of 11 structures with a nascent helical structure of the N-terminus. B) Cartoon 
model of the lowest global energy model for mNGF with the position of the loops indicated. 
The accepted nomenclature for neutrophins was used. C) Structural alignment of the X-ray 
crystal structures of mNGF. They are color coded in green (1BTG, protomers B,C), grey 
(4EAX, protomers A,B), red (4XPJ). 
 
Figure 2 – NGF is in a conformational exchange regime.  
A) Effect of a temperature scan from 10°C  to 30°C on the 15N HSQC spectra of NGF.  
B) Close-up of one of the regions of the 2D 1H-15N-HSQC at 30°C showing the presence 
of double species. In blue the main species, in red the secondary ones.  
C) Mapping on NGF structure (blue) of the residues showing a double species in the 
spectra (red). The residues interested by the peak splitting are: V36-I44, A89-T91, W99 
(amidic indole only).  
 
Figure 3 - The dynamics of NGF in solution.  
A) 15N - NMR relaxation studies. Plots of the T1/T2 and 15N-1H NOE of mNGF at 600 
MHz and 30°C. The secondary structure is shown above.  
B) R.m.s.d. fluctuations along the 200 ns MD simulation of NGF versus residue position for 
the two protomers (blue – protomer x; red – protomer y).  
C) Evolution of the distances (Å), along the 200 ns MD simulation, between atoms 
engaged in the hydrogen bonds that stabilize the helical structure of the N-terminus mNGF 
(grey – protomer x; black – protomer y). 
D) Percentage of time, along the 200 ns MD simulation, that each residue spent in a 
helical conformation along the trajectory. 
 
Figure 4 – anti-NGF Antibody-antigen interaction.  
A) Superimposition of the 15N -HSQC recorded at the different points of the titration of 
mNGF with the MAb αD11. The spectra were recorded at 30°C. Red: 0 antibody 
equivalents; Green: 0.15 antibody equivalents; Purple: 0.45 antibody equivalents. 
B) Structure of mNGF (PDB ID 1BET) with the residues of the αD11 epitope highlighted in 
green and cyan. Residues found to be affected in the present titration but not previously 
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known to participate to the epitope are highlighted in red. Insets: Close-ups of the residues 
most affected by broadening or chemical shift perturbation. Their positions on the structure 
is indicated by arrows. 
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